CN108852865A - A kind of fullerene topical composition - Google Patents
A kind of fullerene topical composition Download PDFInfo
- Publication number
- CN108852865A CN108852865A CN201810777244.9A CN201810777244A CN108852865A CN 108852865 A CN108852865 A CN 108852865A CN 201810777244 A CN201810777244 A CN 201810777244A CN 108852865 A CN108852865 A CN 108852865A
- Authority
- CN
- China
- Prior art keywords
- oil
- fullerene
- composition
- cosmetic
- poe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 title claims abstract description 117
- 229910003472 fullerene Inorganic materials 0.000 title claims abstract description 112
- 239000000203 mixture Substances 0.000 title claims abstract description 99
- 230000000699 topical effect Effects 0.000 title description 2
- 239000002537 cosmetic Substances 0.000 claims abstract description 32
- 238000002360 preparation method Methods 0.000 claims abstract description 20
- 239000012752 auxiliary agent Substances 0.000 claims abstract description 9
- -1 Isodecyl Chemical group 0.000 claims description 42
- 239000003921 oil Substances 0.000 claims description 27
- 235000019198 oils Nutrition 0.000 claims description 27
- 239000006185 dispersion Substances 0.000 claims description 23
- 239000000654 additive Substances 0.000 claims description 22
- 229940119170 jojoba wax Drugs 0.000 claims description 17
- AMUTYVGRCVFCCD-UHFFFAOYSA-N 5,6-diaminopyridine-3-carboxylic acid Chemical compound NC1=CC(C(O)=O)=CN=C1N AMUTYVGRCVFCCD-UHFFFAOYSA-N 0.000 claims description 16
- 230000002087 whitening effect Effects 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 239000000463 material Substances 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 9
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 230000000996 additive effect Effects 0.000 claims description 8
- 150000002148 esters Chemical class 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 230000001153 anti-wrinkle effect Effects 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 7
- 230000003255 anti-acne Effects 0.000 claims description 6
- 230000003779 hair growth Effects 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 claims description 5
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 230000003796 beauty Effects 0.000 claims description 5
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 claims description 5
- 229940078812 myristyl myristate Drugs 0.000 claims description 5
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 claims description 5
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- 208000003351 Melanosis Diseases 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000004480 active ingredient Substances 0.000 claims description 3
- 229910052747 lanthanoid Inorganic materials 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- 229910052706 scandium Inorganic materials 0.000 claims description 3
- 238000013268 sustained release Methods 0.000 claims description 3
- 239000012730 sustained-release form Substances 0.000 claims description 3
- 229910052727 yttrium Inorganic materials 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- 229940071160 cocoate Drugs 0.000 claims 3
- BILPUZXRUDPOOF-UHFFFAOYSA-N stearyl palmitate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC BILPUZXRUDPOOF-UHFFFAOYSA-N 0.000 claims 2
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 claims 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 claims 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 235000021323 fish oil Nutrition 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 238000000265 homogenisation Methods 0.000 claims 1
- UKGRTCZMPQERFQ-UHFFFAOYSA-N octadecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)C(C)O UKGRTCZMPQERFQ-UHFFFAOYSA-N 0.000 claims 1
- GAQPWOABOQGPKA-UHFFFAOYSA-N octadecyl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCC GAQPWOABOQGPKA-UHFFFAOYSA-N 0.000 claims 1
- VNLRTFSQCPNNIM-UHFFFAOYSA-N octadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC VNLRTFSQCPNNIM-UHFFFAOYSA-N 0.000 claims 1
- 229960002446 octanoic acid Drugs 0.000 claims 1
- SQABAALQCGKFFO-UHFFFAOYSA-N octanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCC(O)=O SQABAALQCGKFFO-UHFFFAOYSA-N 0.000 claims 1
- 150000005691 triesters Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 210000003491 skin Anatomy 0.000 description 33
- 239000000194 fatty acid Substances 0.000 description 28
- 235000014113 dietary fatty acids Nutrition 0.000 description 26
- 229930195729 fatty acid Natural products 0.000 description 26
- 239000003795 chemical substances by application Substances 0.000 description 25
- 239000000047 product Substances 0.000 description 19
- 238000002474 experimental method Methods 0.000 description 16
- 239000000839 emulsion Substances 0.000 description 15
- 239000006210 lotion Substances 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 14
- 239000006071 cream Substances 0.000 description 14
- 235000019388 lanolin Nutrition 0.000 description 14
- 229940039717 lanolin Drugs 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 239000004094 surface-active agent Substances 0.000 description 12
- 238000003786 synthesis reaction Methods 0.000 description 12
- 239000004359 castor oil Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 150000004665 fatty acids Chemical class 0.000 description 10
- 235000019438 castor oil Nutrition 0.000 description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- 239000000499 gel Substances 0.000 description 8
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 208000002874 Acne Vulgaris Diseases 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 7
- 206010000496 acne Diseases 0.000 description 7
- 235000019864 coconut oil Nutrition 0.000 description 7
- 239000003240 coconut oil Substances 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 230000002500 effect on skin Effects 0.000 description 6
- 239000003112 inhibitor Substances 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000003760 tallow Substances 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920001214 Polysorbate 60 Polymers 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000000344 soap Substances 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 239000002280 amphoteric surfactant Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000005642 Oleic acid Substances 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 230000003656 anti-hair-loss Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 239000010495 camellia oil Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 239000003974 emollient agent Substances 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 239000000865 liniment Substances 0.000 description 3
- 239000002502 liposome Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000001593 sorbitan monooleate Substances 0.000 description 3
- 229940035049 sorbitan monooleate Drugs 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 2
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 2
- WMYINDVYGQKYMI-UHFFFAOYSA-N 2-[2,2-bis(hydroxymethyl)butoxymethyl]-2-ethylpropane-1,3-diol Chemical compound CCC(CO)(CO)COCC(CC)(CO)CO WMYINDVYGQKYMI-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- ZFGOPJASRDDARH-UHFFFAOYSA-N 3-[[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C(C2)C1(C)CCC2OC1CC2=CCC3C4CCC(C(C)CCCC(C)C)C4(C)CCC3C2(C)CC1 ZFGOPJASRDDARH-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 2
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 description 2
- 210000001789 adipocyte Anatomy 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 239000003945 anionic surfactant Substances 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 2
- 229940100463 hexyl laurate Drugs 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002602 lanthanoids Chemical class 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 239000004005 microsphere Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- 239000012170 montan wax Substances 0.000 description 2
- 238000011580 nude mouse model Methods 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 229920002601 oligoester Polymers 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920001083 polybutene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000003658 preventing hair loss Effects 0.000 description 2
- XOJVVFBFDXDTEG-UHFFFAOYSA-N pristane Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)C XOJVVFBFDXDTEG-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 235000011803 sesame oil Nutrition 0.000 description 2
- 239000008159 sesame oil Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 229940104261 taurate Drugs 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical class CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- ZYJZBFYRVKLOAA-KRWDZBQOSA-N (2s)-2-(hexadecanoylamino)butanedioic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CC(O)=O ZYJZBFYRVKLOAA-KRWDZBQOSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- XWZPJRNVELUELY-GDVGLLTNSA-N 2,3-dihydroxypropyl (2s)-5-oxopyrrolidine-2-carboxylate Chemical compound OCC(O)COC(=O)[C@@H]1CCC(=O)N1 XWZPJRNVELUELY-GDVGLLTNSA-N 0.000 description 1
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- LNCJHVLXANMHHD-UHFFFAOYSA-N 2-[2-heptadecyl-1-(2-hydroxyethyl)-4,5-dihydroimidazol-1-ium-1-yl]acetate Chemical compound CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC([O-])=O LNCJHVLXANMHHD-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- WBIQQQGBSDOWNP-UHFFFAOYSA-N 2-dodecylbenzenesulfonic acid Chemical compound CCCCCCCCCCCCC1=CC=CC=C1S(O)(=O)=O WBIQQQGBSDOWNP-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- JVXJFNLEXLGQIO-UHFFFAOYSA-N 2-hexyldecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC JVXJFNLEXLGQIO-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- XATHTZNVYDUDGS-UHFFFAOYSA-N 2-octadecylpropane-1,2,3-triol Chemical compound CCCCCCCCCCCCCCCCCCC(O)(CO)CO XATHTZNVYDUDGS-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- RBOCKOCAICAFQJ-UHFFFAOYSA-N 4,4-bis(1-hydroxypropyl)heptane-3,5-diol Chemical compound C(C)C(O)C(C(O)CC)(C(O)CC)C(O)CC RBOCKOCAICAFQJ-UHFFFAOYSA-N 0.000 description 1
- ZQXRINMCMHCYBD-UHFFFAOYSA-N 4-(2-ethylhexoxy)-4-oxobutanoic acid Chemical compound CCCCC(CC)COC(=O)CCC(O)=O ZQXRINMCMHCYBD-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- MVJSIAIXMFGVSA-UHFFFAOYSA-N 6-(2-hexyldecoxy)-6-oxohexanoic acid Chemical compound CCCCCCCCC(CCCCCC)COC(=O)CCCCC(O)=O MVJSIAIXMFGVSA-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 229940100578 Acetylcholinesterase inhibitor Drugs 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 102000010637 Aquaporins Human genes 0.000 description 1
- 108010063290 Aquaporins Proteins 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 208000035484 Cellulite Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 230000028937 DNA protection Effects 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 102000004237 Decorin Human genes 0.000 description 1
- 108090000738 Decorin Proteins 0.000 description 1
- 102000000541 Defensins Human genes 0.000 description 1
- 108010002069 Defensins Proteins 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101150101095 Mmp12 gene Proteins 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N N-methylaminoacetic acid Natural products C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 description 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 description 1
- CQVPPLWYIDMWDA-UHFFFAOYSA-N OS(=O)(=O)c1ccccc1.CCCCCCCCCCCC[Na] Chemical compound OS(=O)(=O)c1ccccc1.CCCCCCCCCCCC[Na] CQVPPLWYIDMWDA-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010049752 Peau d'orange Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004147 Sorbitan trioleate Substances 0.000 description 1
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000005211 alkyl trimethyl ammonium group Chemical group 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- ULBTUVJTXULMLP-UHFFFAOYSA-N butyl octadecanoate Chemical group CCCCCCCCCCCCCCCCCC(=O)OCCCC ULBTUVJTXULMLP-UHFFFAOYSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910021387 carbon allotrope Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001766 catechin derivatives Chemical class 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000004766 cell nucleus structure Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000544 cholinesterase inhibitor Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 230000011382 collagen catabolic process Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- LJWQJLWRBIHMPG-UHFFFAOYSA-N decanedioic acid;2-hexyldecanoic acid Chemical compound OC(=O)CCCCCCCCC(O)=O.CCCCCCCCC(C(O)=O)CCCCCC LJWQJLWRBIHMPG-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000007854 depigmenting agent Substances 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- DDXLVDQZPFLQMZ-UHFFFAOYSA-M dodecyl(trimethyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCC[N+](C)(C)C DDXLVDQZPFLQMZ-UHFFFAOYSA-M 0.000 description 1
- 229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
- 229940060296 dodecylbenzenesulfonic acid Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- OIKBVOIOVNEVJR-UHFFFAOYSA-N hexadecyl 6-methylheptanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCC(C)C OIKBVOIOVNEVJR-UHFFFAOYSA-N 0.000 description 1
- LSICWCQVUKVJAW-UHFFFAOYSA-N hexanoyl decanoate Chemical compound CCCCCCCCCC(=O)OC(=O)CCCCC LSICWCQVUKVJAW-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000027829 mitochondrial depolarization Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ONLRKTIYOMZEJM-UHFFFAOYSA-N n-methylmethanamine oxide Chemical compound C[NH+](C)[O-] ONLRKTIYOMZEJM-UHFFFAOYSA-N 0.000 description 1
- 239000002088 nanocapsule Substances 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 239000006070 nanosuspension Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- UVPGECJLXBGLDW-UHFFFAOYSA-N octadecan-7-ol Chemical compound CCCCCCCCCCCC(O)CCCCCC UVPGECJLXBGLDW-UHFFFAOYSA-N 0.000 description 1
- 229940077397 octyldodecyl lactate Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 238000007557 optical granulometry Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 229940116422 propylene glycol dicaprate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- BTURAGWYSMTVOW-UHFFFAOYSA-M sodium dodecanoate Chemical compound [Na+].CCCCCCCCCCCC([O-])=O BTURAGWYSMTVOW-UHFFFAOYSA-M 0.000 description 1
- 229940082004 sodium laurate Drugs 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 229940045885 sodium lauroyl sarcosinate Drugs 0.000 description 1
- 229940045870 sodium palmitate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- GGXKEBACDBNFAF-UHFFFAOYSA-M sodium;hexadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCC([O-])=O GGXKEBACDBNFAF-UHFFFAOYSA-M 0.000 description 1
- ZNYIJXQYUNSKDX-NTISSMGPSA-M sodium;hydron;(2s)-2-(tetradecanoylamino)pentanedioate Chemical compound [Na+].CCCCCCCCCCCCCC(=O)N[C@H](C([O-])=O)CCC(O)=O ZNYIJXQYUNSKDX-NTISSMGPSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000002316 solid fats Nutrition 0.000 description 1
- 239000002047 solid lipid nanoparticle Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000019337 sorbitan trioleate Nutrition 0.000 description 1
- 229960000391 sorbitan trioleate Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008227 sterile water for injection Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 239000002383 tung oil Substances 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一油溶性富勒烯外用组合物及其制备方法和应用,油溶性富勒烯外用组合物其含有油溶性助剂以及在油溶性助剂中溶解的富勒烯,该组合物具有美容的效果。
The invention discloses an oil-soluble fullerene external composition and its preparation method and application. The oil-soluble fullerene external composition contains an oil-soluble auxiliary agent and fullerene dissolved in the oil-soluble auxiliary agent. The composition It has a cosmetic effect.
Description
技术领域technical field
本发明涉及一种日化领域,特别涉及一种具有美容作用的外用组合物。The invention relates to the field of daily chemicals, in particular to an external composition with cosmetic effect.
背景技术Background technique
1985年科学家Kroto、Smalley、Curl等人在研究太空深处的碳元素时发现了C60富勒烯,1996年三人因此而获得诺贝尔化学奖。富勒烯与金刚石、石墨同为碳的同素异形体。C60是由60个碳原子组成的球形分子,由12个五边形和20个六边形组成,每个碳原子和相邻的三个碳原子通过SP2杂化成键,因形似足球而被称为CITE。具有笼状碳原子团簇结构的系列分子被统称为分子被统称为有笼Note><Cite><Au烯衍生物及杂环富勒烯等。常见的C60、C70、C76、C84等种类。In 1985, scientists Kroto, Smalley, Curl and others discovered C60 fullerene when studying carbon elements in deep space. In 1996, they won the Nobel Prize in Chemistry for this. Fullerene, diamond and graphite are allotropes of carbon. C60 is a spherical molecule composed of 60 carbon atoms, consisting of 12 pentagons and 20 hexagons. Each carbon atom and the adjacent three carbon atoms form bonds through SP2 hybridization. It is named for its shape like a football. Called CITE. A series of molecules with a caged carbon atom cluster structure are collectively referred to as molecules are collectively referred to as caged Note><Cite><Auene derivatives and heterocyclic fullerenes. Common C60, C70, C76, C84 and other types.
富勒烯的多个P轨道构成的大π键共轭体系,使得其具有较强的接受电子的能力,因其独特的结构和理化性质,使其具有优异的清除自由基性能,被称为“自由基海绵”,同时还表现出了优异的抗氧化性能。使其在化妆品材料、生物医药等方面得到广泛关注。The large π-bonded conjugated system composed of multiple P orbitals of fullerene makes it have a strong ability to accept electrons. Because of its unique structure and physical and chemical properties, it has excellent free radical scavenging performance, known as The "free radical sponge" also exhibits excellent antioxidant properties. It has been widely concerned in cosmetic materials, biomedicine and other aspects.
通过将C60嵌入表面活性剂中,C60仍可以消除细胞内的活性氧,抑制线粒体的去极化、半胱氨酸蛋白酶的激活、细胞膜上磷脂酰丝氨酸的曝光以及DNA的分裂,C60表现出了保护细胞不被氧化凋亡的作用。C60脂质体复合物通过防御UVA对皮肤结构,细胞核和胶原纤维的破坏以及向人体皮肤组织的渗透来起到抗氧化作用,是维他命C的172倍,能够亲和自由基。By embedding C60 into surfactants, C60 can still eliminate reactive oxygen species in cells, inhibit mitochondrial depolarization, activation of cysteine proteases, exposure of phosphatidylserine on cell membranes, and DNA cleavage, and C60 exhibits Protect cells from oxidative apoptosis. C60 liposome complex plays an anti-oxidant role by defending against UVA damage to skin structure, cell nucleus and collagen fibers, and penetrating into human skin tissue. It is 172 times that of vitamin C and can affinity free radicals.
Fathi Moussa教授长期从事C60的性质研究工作,作为将富勒烯溶于橄榄油中进行研究的第一人,他们通过对老鼠10-17个月每两周喂一次(每公斤体重喂4毫克富勒烯),对照组老鼠17-38个月死亡,而试验组寿命则延长至59-66个月,发现富勒烯具有长寿保健功能。期间无论体重,生理表现无一异常,并未发现C60具有毒性和生物遗传性,相反一定量的C60具有清除自由基性能,从而使动物免受过多自由基产生的危害。Professor Fathi Moussa has been engaged in the research on the properties of C60 for a long time. As the first person to study dissolving fullerene in olive oil, they fed mice 10-17 months every two weeks (feeding 4 mg richerene per kg body weight) Fullerene), the mice in the control group died within 17-38 months, while the life span of the experimental group was extended to 59-66 months. It was found that fullerene has a longevity health care function. During the period, regardless of body weight, there was no abnormality in physiological performance, and no toxicity or biological heredity of C60 was found. On the contrary, a certain amount of C60 has the ability to scavenge free radicals, thereby protecting animals from the harm of excessive free radicals.
作为外用品,已有专利报道了富勒烯相关的产品,例如C60-PVP,申请号:200480005008.1,200580049615.2,由于制备工艺及PVP与C60的复合特性限制,在该复合物中,C60的含量不超过1%,加之PVP有明显的成膜性,过多的涂敷在皮肤表层后对某些化妆品功效的发挥会起到一定的阻碍作用。C60-角鲨烷,申请号201510427642.4,但是C60在角鲨烷中的溶解度有限,同时角鲨烷是油溶液,使得该系列产品的使用受限。富勒烯纳米悬浮液CN201510971343.7,但是该成分为大颗粒的富勒烯成分,添加到配方中后会影响配方稳定性和外观及使用舒适度,并且大颗粒的富勒烯成分很难在皮肤起到修复作用,仅能附着在皮肤表层,起到屏障作用。As an external product, fullerene-related products have been reported in patents, such as C60-PVP, application numbers: 200480005008.1, 200580049615.2. Due to the limitations of the preparation process and the composite characteristics of PVP and C60, the content of C60 in this composite is not high. More than 1%, in addition, PVP has obvious film-forming properties, and excessive application on the surface of the skin will hinder the performance of certain cosmetics. C60-squalane, application number 201510427642.4, but the solubility of C60 in squalane is limited, and squalane is an oil solution, which limits the use of this series of products. Fullerene nano-suspension CN201510971343.7, but this component is a fullerene component with large particles, which will affect the stability, appearance and use comfort of the formula after being added to the formula, and the fullerene component with large particles is difficult to remove The skin plays a repairing role and can only adhere to the surface layer of the skin to act as a barrier.
富勒烯是一种非极性分子,具有强烈的疏水性,仅能够溶于对生物体有害的非极性有机溶剂如甲苯、苯、环己烷、氯仿中。富勒烯本身疏水性性质直接影响了其生物活性的发挥,为了更好的促进吸收,将富勒烯制成易于皮肤快速吸收其呈分子状态的溶液型,将富勒烯复配皮肤亲善型的成分还没有被研究过。Fullerene is a non-polar molecule with strong hydrophobicity and can only be dissolved in non-polar organic solvents such as toluene, benzene, cyclohexane, and chloroform that are harmful to organisms. The hydrophobic nature of fullerene itself directly affects its biological activity. In order to better promote absorption, fullerene is made into a solution type that is easy for the skin to absorb quickly and is in a molecular state. Fullerene is compounded with a skin-friendly type components have not been studied.
本发明专利发明的含富勒烯的组合物,确保了富勒烯以分子状态分散于所选溶剂中,得到的含富勒烯的组合物性质稳定,可用于任何外用配方。本发明的组合物中富勒烯是溶解状态,作为外用产品成分,可以更好的作用于皮肤。The fullerene-containing composition invented by the patent of the present invention ensures that the fullerene is dispersed in the selected solvent in a molecular state, and the obtained fullerene-containing composition has stable properties and can be used in any external formulation. The fullerene in the composition of the present invention is in a dissolved state, and as an external product component, it can better act on the skin.
发明内容Contents of the invention
本发明的目的在于提供一种富勒烯组合物,该组合物中富勒烯呈现溶解状态,且快速吸收,具有美白祛斑,祛皱,抗痘,防脱固发的效果。The purpose of the present invention is to provide a fullerene composition, in which the fullerene is in a dissolved state and absorbed quickly, and has the effects of whitening and removing spots, removing wrinkles, anti-acne, and preventing hair loss and solidification.
在一方面,本发明提供了一种富勒烯组合物,其含有油溶性助剂以及在油溶性助剂中溶解或分散的富勒烯。In one aspect, the present invention provides a fullerene composition comprising an oil solubility aid and fullerene dissolved or dispersed in the oil solubility aid.
在一方面,本发明提供了一种富勒烯分散体系,所述体系含有富勒烯和油溶性助剂,其特征在于所述分散体系中50%以上,例如60%、70%、80%、90%、95%、99%以上的粒径小于5nm。In one aspect, the present invention provides a fullerene dispersion system, the system contains fullerene and oil solubility additives, characterized in that more than 50% of the dispersion system, such as 60%, 70%, 80% , 90%, 95%, 99% or more of the particle size is less than 5nm.
在一方面,本发明提供了一种富勒烯组合物或者分散体系的制备方法,其特征在于,包括如下步骤:取富勒烯粉末,油溶性助剂,混合均匀后,投入高压均质机中,50-500MPa,优选100-300MPa,进一步优选200MPa均质1-10次,优选3-8次,进一步优选5次,然后将物料温度控制在0-25℃,优选5-20℃,进一步优选10-15℃,搅拌1-20h,优选5-15h,进一步优选12h,然后离心和/或过滤得到产物。In one aspect, the present invention provides a method for preparing a fullerene composition or dispersion system, which is characterized in that it comprises the following steps: taking fullerene powder and an oil-soluble additive, mixing them uniformly, and putting them into a high-pressure homogenizer In, 50-500MPa, preferably 100-300MPa, more preferably 200MPa homogeneous 1-10 times, preferably 3-8 times, more preferably 5 times, then control the temperature of the material at 0-25°C, preferably 5-20°C, further Stir preferably at 10-15°C for 1-20h, preferably 5-15h, more preferably 12h, then centrifuge and/or filter to obtain the product.
在一方面,本发明提供了使用本发明的方法制备的富勒烯组合物或者分散体系。In one aspect, the invention provides a fullerene composition or dispersion prepared using the method of the invention.
根据前述任一方面,本发明提供了一种富勒烯组合物,其特征在于,除了油溶性助剂和富勒烯之外,还含有至少一种抗氧化剂。According to any one of the foregoing aspects, the present invention provides a fullerene composition, which is characterized in that, in addition to the oil-soluble additive and fullerene, it also contains at least one antioxidant.
根据前述任一方面,本发明提供了一种富勒烯组合物,其特征在于,除了油溶性助剂和富勒烯之外,还含有至少一种另外的活性成分。According to any one of the aforementioned aspects, the present invention provides a fullerene composition, which is characterized in that, in addition to the oil-soluble additive and fullerene, it also contains at least one other active ingredient.
根据前述任一方面,本发明提供一种富勒烯组合物在制备美容或化妆用品中的应用。According to any one of the foregoing aspects, the present invention provides an application of a fullerene composition in the preparation of cosmetic or cosmetic products.
根据前述任一方面,本发明提供一种富勒烯组合物在制备用于美容或化妆用途的器械中的应用。According to any one of the foregoing aspects, the present invention provides an application of a fullerene composition in the preparation of a device for beauty or cosmetic use.
根据前述任一方面,本发明提供一种美容的方法,所述方法包括向受试者施用有效量的本发明的组合物或包含本发明组合物的药剂,任选地,所述美容效果包括美白祛斑,祛皱,抗痘,防脱固发的至少一种。According to any of the foregoing aspects, the present invention provides a cosmetic method, the method comprising administering to a subject an effective amount of the composition of the present invention or a medicament comprising the composition of the present invention, optionally, the cosmetic effect includes At least one of whitening, anti-freckle, anti-wrinkle, anti-acne, anti-hair loss.
根据前述任一方面,本发明组合物还可以与其他辅料一起使用。According to any of the aforementioned aspects, the composition of the present invention can also be used together with other auxiliary materials.
根据前述任一方面,本发明组合物可以与表面活性剂一起使用。According to any of the preceding aspects, the compositions of the invention may be used together with a surfactant.
根据前述任一方面,本发明组合物可以被加入到化妆品或药物递送系统和/或缓释系统中。According to any of the preceding aspects, the composition of the invention may be incorporated into a cosmetic or pharmaceutical delivery system and/or a sustained release system.
根据前述任一方面,所述油溶性助剂选自:荷荷芭油、辛酸葵酸甘油三酯、棕榈酸异辛酯、棕榈酸异丙酯、肉豆蔻酸肉豆蔻酯中的至少一种,优选地,所述油溶性助剂为荷荷巴油、辛酸葵酸甘油三酯、棕榈酸异辛酯中的至少一种。According to any of the foregoing aspects, the oil-soluble auxiliary agent is selected from at least one of: jojoba oil, capric acid triglyceride, isooctyl palmitate, isopropyl palmitate, and myristyl myristate , preferably, the oil-soluble additive is at least one of jojoba oil, caprylic triglyceride, and isooctyl palmitate.
根据前述任一方面,所述富勒烯为空心富勒烯、金属富勒烯、杂环富勒烯和内嵌富勒烯中的一种或几种。包括但不限于富勒烯C2n、M@C2n、M2@C2n、MA@C2n、M3N@C2n、M2C2@C2n、M2S@C2n、M2O@C2n和MxA3-xN@C2n中的任一种,其中,M和A均为金属元素,所述M和A均选自Sc、Y和镧系金属元素中的任意一种;30≤n≤60;0≤x≤3,优选地,所述富勒烯为C60、C70、C76、C84,Gd@C82及其衍生物中的任意一种或其混合物,进一步优选地,所述富勒烯为C60。According to any of the foregoing aspects, the fullerene is one or more of hollow fullerenes, metal fullerenes, heterocyclic fullerenes and embedded fullerenes. Including but not limited to fullerenes C 2n , M@C 2n , M 2 @C 2n , MA@C 2n , M 3 N@C 2n , M 2 C 2 @C 2n , M 2 S@C 2n , M 2 Any of O@C 2n and M x A 3-x N@C 2n , wherein M and A are metal elements, and the M and A are selected from any of Sc, Y and lanthanide metal elements One; 30≤n≤60; 0≤x≤3, preferably, the fullerene is any one of C60, C70, C76, C84, Gd@C82 and its derivatives or a mixture thereof, more preferably Preferably, the fullerene is C60.
本发明组合物作为液体制剂的形式例如可以是油性悬浮液、溶液剂,还可以是一种在使用前可用水或其它适宜的载体复配的干燥产品。这种液体制剂可含有常规的添加剂,诸如悬浮剂,例如山梨醇、甲基纤维素、明胶、羟乙基纤维素、羧甲基纤维素、硬脂酸铝凝胶或氢化食用脂肪;溶液剂的制备通常是通过将活性物质溶解在一种载体中,并在将其装入一种适宜的小瓶或安瓿前过滤消毒,然后密封。The composition of the present invention can be in the form of a liquid preparation, for example, an oily suspension, a solution, or a dry product that can be reconstituted with water or other suitable carriers before use. Such liquid preparations may contain conventional additives such as suspending agents, for example sorbitol, methylcellulose, gelatin, hydroxyethylcellulose, carboxymethylcellulose, aluminum stearate gel or hydrogenated edible fats; solutions It is usually prepared by dissolving the active substance in a carrier and filter sterilizing before filling into a suitable vial or ampoule, which is then hermetically sealed.
在一方面,本发明提供一种富勒烯组合物制备水剂方法:将富勒烯组合物按照比例与水混合后,搅拌均匀,然后均质好,加入防腐剂和香精得到水剂。In one aspect, the present invention provides a method for preparing an aqueous solution from a fullerene composition: mix the fullerene composition with water in proportion, stir evenly, and then homogenize well, then add preservatives and flavors to obtain the aqueous solution.
本发明组合物制成乳剂的形式,可包含常规的乳化剂,助乳剂、表面活性剂等。The composition of the present invention is prepared in the form of an emulsion, which may contain conventional emulsifiers, co-emulsion agents, surfactants and the like.
在一方面,本发明提供一种富勒烯组合物制备乳剂方法:将富勒烯组合物按照比例与乳化剂混合,然后进行均质,成乳状液或膏体,加入防腐剂和香精得到乳剂。In one aspect, the present invention provides a method for preparing an emulsion from a fullerene composition: mixing the fullerene composition with an emulsifier in proportion, then homogenizing, forming an emulsion or paste, adding preservatives and essences to obtain an emulsion .
在一方面,本发明提供本发明的组合物或分散体系在制备美容或化妆用品中的用途。In one aspect, the invention provides the use of a composition or dispersion according to the invention for the preparation of a cosmetic or cosmetic product.
在一方面,本发明提供本发明的组合物或分散体系在制备用于美容或化妆的器械中的用途。In one aspect, the invention provides the use of a composition or dispersion according to the invention for the manufacture of a cosmetic or make-up device.
根据前述任一方面,所述美容或化妆用品用于美白祛斑,祛皱,抗痘,防霾,生发固发等。According to any one of the foregoing aspects, the beauty or cosmetic product is used for whitening and removing spots, removing wrinkles, anti-acne, anti-haze, hair growth and strengthening, etc.
附图说明Description of drawings
图1:电镜实验结果。Figure 1: Electron microscope experiment results.
图2:祛痘实验。Figure 2: Acne removal experiment.
图3:祛痘实验定量结果。Figure 3: Quantitative results of the acne removal experiment.
图4:美白实验结果。Figure 4: Whitening experiment results.
图5:防霾实验结果。Figure 5: Anti-haze experiment results.
具体实施方式Detailed ways
下面结合附图,对本发明的具体实施方式进行详细描述,但应当理解本发明的保护范围并不受具体实施方式的限制。The specific embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings, but it should be understood that the protection scope of the present invention is not limited by the specific embodiments.
除非另有其它明确表示,否则在整个说明书和权利要求书中,术语“包括”或其变换如“包含”或“包括有”等等将被理解为包括所陈述的元件或组成部分,而并未排除其它元件或其它组成部分。Unless expressly stated otherwise, throughout the specification and claims, the term "comprise" or variations thereof such as "includes" or "includes" and the like will be understood to include the stated elements or constituents, and not Other elements or other components are not excluded.
在一个实施方案中,本发明提供了一种富勒烯组合物,其含有油溶性助剂以及在油溶性助剂中溶解或分散的富勒烯,任选地,所述的富勒烯浓度为0.01-5mg/ml,优选0.05-3mg/ml,更优选0.1-2mg/ml,进一步优选1mg/ml。In one embodiment, the present invention provides a fullerene composition, which contains oil-soluble additives and fullerenes dissolved or dispersed in oil-soluble additives, optionally, the fullerene concentration 0.01-5 mg/ml, preferably 0.05-3 mg/ml, more preferably 0.1-2 mg/ml, further preferably 1 mg/ml.
在一个实施方案中,本发明提供了一种富勒烯分散体系,所述体系含有富勒烯和油溶性助剂,其特征在于所述分散体系中50%以上,例如60%、70%、80%、90%、95%、99%以上的粒径小于5nm。In one embodiment, the present invention provides a fullerene dispersion system, the system contains fullerene and oil solubility additives, characterized in that more than 50% of the dispersion system, such as 60%, 70%, 80%, 90%, 95%, 99% or more of the particle size is less than 5nm.
在一个实施方案中,本发明提供了一种富勒烯组合物或者分散体系的制备方法,其特征在于,包括如下步骤:取富勒烯粉末,油溶性助剂,混合均匀后,投入高压均质机中,50-500MPa,优选100-300MPa,进一步优选200MPa均质1-10次,优选3-8次,进一步优选5次,然后将物料温度控制在0-25℃,优选5-20℃,进一步优选10-15℃,搅拌1-20h,优选5-15h,进一步优选12h,然后离心和/或过滤得到产物。In one embodiment, the present invention provides a method for preparing a fullerene composition or dispersion system, which is characterized in that it includes the following steps: take fullerene powder, oil-soluble additives, mix them uniformly, and put them into a high-pressure homogeneous In the quality machine, 50-500MPa, preferably 100-300MPa, more preferably 200MPa homogenize 1-10 times, preferably 3-8 times, more preferably 5 times, and then control the temperature of the material at 0-25°C, preferably 5-20°C , further preferably at 10-15°C, stirring for 1-20h, preferably 5-15h, more preferably 12h, and then centrifuging and/or filtering to obtain the product.
在一个实施方案中,本发明提供了一种富勒烯组合物,其特征在于,除了油溶性助剂和富勒烯之外,还含有至少一种抗氧化剂,所述抗氧化剂选自超氧化物歧化酶、甘露醇、组氨酸、色氨酸、胆红素、槲皮黄素、槲皮苷、多酚、原花青素、生育三烯酚、儿茶酸、儿茶酸衍生物、芦丁及其衍生物、五倍子酸及其衍生物、泛醌、虾青素、胡萝卜素、以及其他的类胡萝卜素类物质及其衍生物和它们的盐、维生素B类及其衍生物和它们的盐、维生素D类及其衍生物和它们的盐、维生素E类及其衍生物和它们的盐、二丁基羟基甲苯以及丁基羟基苯甲醚中的至少一种。In one embodiment, the present invention provides a fullerene composition characterized in that, in addition to oil-soluble additives and fullerenes, it also contains at least one antioxidant selected from superoxidized dismutase, mannitol, histidine, tryptophan, bilirubin, quercetin, quercetin, polyphenols, proanthocyanidins, tocotrienols, catechin, catechin derivatives, rutin and Its derivatives, gallic acid and its derivatives, ubiquinone, astaxanthin, carotene, and other carotenoids and their derivatives and their salts, vitamin B and their derivatives and their salts, At least one of vitamin Ds and their derivatives and their salts, vitamin Es and their derivatives and their salts, dibutylhydroxytoluene and butylhydroxyanisole.
在一个实施方案中,本发明提供了一种富勒烯组合物,其特征在于,除了油溶性助剂和富勒烯之外,还含有至少一种另外的活性成分,所述活性成分包括但不限于:基质金属弹性蛋白酶抑制剂,黑素合成刺激剂或抑制剂,增白剂或脱色剂,色素原形成剂,仿晒剂,抗老化剂,NO-合酶抑制剂,抗氧化剂,自由基清除剂和/或抗大气污染剂,抗糖化剂,乳化剂,润肤剂,有机溶剂,液体推进剂,皮肤调节剂如湿润剂、保留水分的物质、α羟基酸、β羟基酸、保湿剂、表皮水解酶、维生素、色素或着色剂,染料,凝胶聚合物,增厚剂,表面活性剂,软化剂,抗皱剂,能够减少或治疗眼袋的药剂,去角质剂,抗微生物剂,杀真菌剂,抑真菌剂,杀细菌剂,抑细菌剂,真皮或表皮大分子合成刺激剂和/或能够阻止或抑制真皮或表皮大分子降解的药剂,胶原蛋白合成刺激剂,弹性蛋白合成刺激剂,核心蛋白多糖合成刺激剂,层粘连蛋白合成刺激剂,防御素合成刺激剂,分子伴侣合成刺激剂,水通道蛋白合成刺激剂,透明质酸合成刺激剂,脂质和角质层的组分合成刺激剂,神经酰胺合成刺激剂,胶原蛋白降解抑制剂,弹性蛋白降解抑制剂,成纤维细胞增殖刺激剂,角质形成细胞增殖刺激剂,脂肪细胞增殖刺激剂,黑素细胞增殖刺激剂,角质形成细胞分化刺激剂,脂肪细胞分化刺激剂,乙酰胆碱酯酶抑制剂,皮肤弛缓剂,糖胺聚糖合成刺激剂,DNA修复剂,DNA保护剂,止痒剂,用于治疗和/或护理敏感皮肤的药剂,固化剂,抗萎缩纹剂,收敛剂,调节皮脂产生的药剂,脂肪分解刺激剂,抗蜂窝组织炎剂,愈合刺激剂,愈合辅助佐剂,上皮再形成刺激剂,上皮再形成辅助佐剂,细胞因子生长因子,镇静剂,抗炎剂,作用于毛细管循环和/或微循环的药剂,血管生成刺激剂,血管通透性抑制剂,作用于细胞代谢的药剂,用于改善真皮-表皮接合的药剂,促进毛发生长的药剂,抑制或延缓毛发生长的药剂,防腐剂,芳香剂,螯合剂,植物提取物,精油,海洋提取物,来自生物发酵过程的药剂,矿物盐,细胞提取物和遮光剂(针对紫外线A和/或紫外线B起作用的有机的或矿物的光保护剂),或其混合物。In one embodiment, the present invention provides a fullerene composition, characterized in that, in addition to oil-soluble additives and fullerenes, it also contains at least one additional active ingredient, which includes but Not limited to: matrix metalloelastase inhibitors, melanin synthesis stimulators or inhibitors, whitening or depigmenting agents, chromogen formers, self-tanning agents, antiaging agents, NO-synthase inhibitors, antioxidants, free Base scavengers and/or anti-air pollution agents, anti-glycation agents, emulsifiers, emollients, organic solvents, liquid propellants, skin conditioning agents such as humectants, moisture-retaining substances, alpha hydroxy acids, beta hydroxy acids, moisturizing agents, epidermal hydrolytic enzymes, vitamins, pigments or coloring agents, dyes, gel polymers, thickening agents, surfactants, emollients, anti-wrinkle agents, agents capable of reducing or treating bags under the eyes, exfoliating agents, antimicrobial agents, Fungicide, antifungal agent, bactericide, bacteriostatic agent, dermal or epidermal macromolecular synthesis stimulator and/or agent capable of preventing or inhibiting dermal or epidermal macromolecular degradation, collagen synthesis stimulator, elastin synthesis stimulator agent, decorin synthesis stimulator, laminin synthesis stimulator, defensin synthesis stimulator, molecular chaperone synthesis stimulator, aquaporin synthesis stimulator, hyaluronic acid synthesis stimulator, lipids and components of the stratum corneum Synthesis stimulator, ceramide synthesis stimulator, collagen degradation inhibitor, elastin degradation inhibitor, fibroblast proliferation stimulator, keratinocyte proliferation stimulator, adipocyte proliferation stimulator, melanocyte proliferation stimulator, keratin Formation cell differentiation stimulator, adipocyte differentiation stimulator, acetylcholinesterase inhibitor, skin relaxant, glycosaminoglycan synthesis stimulator, DNA repair agent, DNA protection agent, antipruritic agent, for the treatment and/or care of sensitive Skin agent, curing agent, anti-atrophic striae agent, astringent, agent for regulating sebum production, lipolysis stimulator, anti-cellulite agent, healing stimulator, healing auxiliary adjuvant, re-epithelialization stimulator, re-epithelialization Auxiliary adjuvants, cytokine growth factors, sedatives, anti-inflammatory agents, agents acting on capillary circulation and/or microcirculation, angiogenesis stimulators, vascular permeability inhibitors, agents acting on cell metabolism, for improving dermis - Epidermal junction agents, agents that promote hair growth, agents that inhibit or delay hair growth, preservatives, fragrances, chelating agents, plant extracts, essential oils, marine extracts, agents from biological fermentation processes, mineral salts, cells Extracts and sunscreens (organic or mineral photoprotectants acting against UVA and/or UVB), or mixtures thereof.
在一个实施方案中,本发明提供一种富勒烯组合物在制备美容或化妆用品中的应用。In one embodiment, the present invention provides an application of a fullerene composition in the preparation of cosmetic or cosmetic products.
在一个实施方案中,所述美容或化妆用品剂型包括但不限于溶液、悬浮液、乳浊液、膏剂、凝胶剂、霜剂、乳液、粉剂、皂、含表面活性剂的清洁剂、油、粉末粉底霜、乳液、粉底霜、蜡基粉底霜、喷剂、搽剂、糊剂和泥敷剂中的任意剂型,例如乳膏剂、复合乳剂、无水组合物、水分散剂、油、乳液、香脂、泡沫、洗液、凝胶、乳膏凝胶、水醇溶液、水二醇溶液、搽剂、盐水溶液、肥皂、洗发剂、调节剂、浆液、油膏、摩丝、软膏剂、粉剂、棒剂、笔剂、喷雾剂、气雾剂、胶囊剂、明胶胶囊、片剂、糖衣片剂、粉剂、颗粒形式、口香糖、溶液、悬浮液、乳剂、糖浆、多糖膜、冻胶、明胶、软膏、霜剂、柔软化妆水、营养化妆水、面膜、精华素、生发剂、洗发剂、漂洗剂、护发素、头发护理剂、凝胶剂、皮肤乳液、皮肤柔软剂、爽肤水、收敛剂、乳液、牛奶乳液、保湿乳液、营养乳液、按摩霜、营养霜、保湿霜、护手霜、粉底霜、营养精华、防晒霜、皂、清洁泡沫、清洁乳、清洁霜、身体乳液以及身体清洁剂、眼袋去除剂、化妆粉底、卸妆洗液、卸妆乳液、眼影、口红、唇彩和唇粉;所述美容或化妆用品的功效包括但不限于:肌肤美白、改善色素沉淀、治疗粉刺、改善皱纹、改善皮肤粗糙、改善油性皮肤、改善干燥肌肤、收缩毛孔、治疗疤痕、治疗面色潮红、治疗脱发、促进生发、治疗烧伤、皮肤杀菌、皮肤杀螨、改善皮肤凹坑、抗痘、防霾中的至少一种。In one embodiment, the cosmetic or cosmetic dosage forms include, but are not limited to, solutions, suspensions, emulsions, ointments, gels, creams, lotions, powders, soaps, surfactant-containing cleansers, oils , powder foundations, lotions, foundations, wax foundations, sprays, liniments, pastes and poultices in any dosage form, such as creams, complex emulsions, anhydrous compositions, aqueous dispersions, oils, Lotions, balms, foams, lotions, gels, cream gels, hydroalcoholic solutions, water glycol solutions, liniments, saline solutions, soaps, shampoos, conditioners, serums, ointments, mousses, ointments powder, stick, pen, spray, aerosol, capsule, gelatin capsule, tablet, sugar-coated tablet, powder, granular form, chewing gum, solution, suspension, emulsion, syrup, polysaccharide film, jelly Gel, gelatin, ointment, cream, softening lotion, nourishing lotion, mask, essence, hair tonic, shampoo, rinse, conditioner, hair conditioner, gel, skin lotion, skin softener , toner, astringent, lotion, milk lotion, moisturizing lotion, nourishing lotion, massage cream, nourishing cream, moisturizing cream, hand cream, foundation cream, nourishing essence, sunscreen, soap, cleansing foam, cleansing milk, cleansing cream, Body lotions and body cleansers, eye bag removers, makeup foundations, makeup remover lotions, makeup remover lotions, eye shadows, lipsticks, lip glosses and lip powders; the effects of said beauty or cosmetic products include but are not limited to: skin whitening, pigmentation improvement, Treatment of acne, improvement of wrinkles, improvement of rough skin, improvement of oily skin, improvement of dry skin, shrinking pores, treatment of scars, treatment of flushing, treatment of hair loss, promotion of hair growth, treatment of burns, skin sterilization, skin killing mites, improvement of skin pits, anti At least one of acne and haze prevention.
在一个实施方案中,本发明提供一种富勒烯组合物在制备用于美容或化妆用途的器械中的应用,所述器械包括但不限于,消毒擦片、消毒棉棒、消毒包、医用敷料湿巾、护理液、清洗液、敷料、液体敷料、创可贴;所述应用可以是本发明组合物附着于特定材料上,所述材料包括但不限于:棉签、湿巾、毛巾、纸巾、纱布、棉棒、无纺布、高分子材料、医用敷料、塑料模型不沾纱布、凡士林油纱布、半通透性膜、泡沫性辅料等。In one embodiment, the present invention provides an application of a fullerene composition in the preparation of devices for cosmetic or make-up purposes, including but not limited to, disinfectant wipes, sterile cotton swabs, sterile packs, medical Dressing wet wipes, nursing solutions, cleaning solutions, dressings, liquid dressings, band-aids; the application may be that the composition of the present invention is attached to a specific material, and the materials include but are not limited to: cotton swabs, wet wipes, towels, paper towels, gauze , cotton swabs, non-woven fabrics, polymer materials, medical dressings, non-stick gauze for plastic models, vaseline oiled gauze, semi-permeable membranes, foam accessories, etc.
在一个实施方案中,本发明组合物还可以与其他辅料一起使用,所述辅料包括透明质酸、油脂类、表面活性剂、防腐剂、香料、粘合剂、增稠剂、络合剂、PH调节剂。In one embodiment, the composition of the present invention can also be used together with other auxiliary materials, which include hyaluronic acid, oils, surfactants, preservatives, spices, adhesives, thickeners, complexing agents, PH regulator.
在一个实施方案中,本发明组合物可以与表面活性剂一起使用,所述表面活性剂选自:阴离子表面活性剂、阳离子表面活性剂、两性表面活性剂、亲油性非离子表面活性剂、亲水性非离子表面活性剂、天然系表面活性剂中的至少一种。In one embodiment, the compositions of the present invention may be used with a surfactant selected from the group consisting of: anionic surfactants, cationic surfactants, amphoteric surfactants, lipophilic nonionic surfactants, lipophilic At least one of water-based nonionic surfactants and natural surfactants.
在一个实施方案中,作为阴离子表面活性剂,例如可以列举皂用原料、月桂酸钠、棕榈酸钠等脂肪酸皂,月桂基硫酸钠、月桂基硫酸钾等高级烷基硫酸酯盐,聚氧乙烯(POE)-月桂基硫酸三乙醇胺、POE-月桂基硫酸钠等烷基醚硫酸酯盐,月桂酰肌氨酸钠等N-酰基肌氨酸,N-肉豆蔻酰基-N-甲基牛磺酸钠、椰子油脂肪酸甲基牛磺酸钠、月桂基甲基牛磺酸钠等高级脂肪酸酰胺磺酸盐,POE-油烯基醚磷酸钠、POE-硬脂酰醚磷酸等磷酸酯盐,二-2-乙基己基磺基琥珀酸钠、单月桂酰基单乙醇酰胺聚氧乙烯磺基琥珀酸钠、月桂基聚丙二醇磺基琥珀酸钠等磺基琥珀酸盐,直链十二烷基苯磺酸钠、直链十二烷基苯磺酸三乙醇胺、直链十二烷基苯磺酸等烷基苯磺酸盐,N-月桂酰基谷氨酸单钠、N-硬脂酰基谷氨酸二钠、N-肉豆蔻酰基-L-谷氨酸单钠等N-酰基谷氨酸盐,硬化椰子油脂肪酸甘油硫酸钠等高级脂肪酸酯硫酸酯盐,土耳其红油等硫酸化油,POE-烷基醚羧酸、POE-烷基烯丙基醚羧酸盐、α-烯烃磺酸盐、高级脂肪酸酯磺酸盐、仲醇硫酸酯盐、高级脂肪酸烷基醇酰胺硫酸酯盐、月桂酰单乙醇酰胺琥珀酸钠、N-棕榈酰天冬氨酸二三乙醇胺以及酪蛋白钠等中的至少一种。In one embodiment, examples of anionic surfactants include soap raw materials, fatty acid soaps such as sodium laurate and sodium palmitate, higher alkyl sulfates such as sodium lauryl sulfate and potassium lauryl sulfate, polyoxyethylene (POE)-Triethanolamine lauryl sulfate, POE-Alkyl ether sulfate salts such as sodium lauryl sulfate, N-acyl sarcosine such as sodium lauroyl sarcosinate, N-myristoyl-N-methyl taurine Higher fatty acid amide sulfonates such as sodium coconut oil fatty acid methyl taurate, sodium lauryl methyl taurate, POE-sodium oleyl ether phosphate, POE-stearyl ether phosphoric acid and other phosphate ester salts, Di-2-Ethylhexyl Sodium Sulfosuccinate, Sodium Monolauroyl Monoethanolamide Polyoxyethylene Sulfosuccinate, Sodium Lauryl Polypropylene Glycol Sulfosuccinate, etc. Sulfosuccinates, Linear Lauryl Sodium benzenesulfonate, triethanolamine linear dodecylbenzenesulfonate, linear dodecylbenzenesulfonic acid and other alkylbenzenesulfonates, monosodium N-lauroyl glutamate, N-stearyl glutamate N-acyl glutamic acid salts such as disodium phosphate, monosodium N-myristoyl-L-glutamate, etc., high fatty acid ester sulfates such as hardened coconut oil fatty acid glycerin sodium sulfate, sulfated oils such as Turkish red oil , POE-alkyl ether carboxylic acid, POE-alkyl allyl ether carboxylate, α-olefin sulfonate, higher fatty acid ester sulfonate, secondary alcohol sulfate, higher fatty acid alkyl alcohol amide sulfate Salt, sodium lauroyl monoethanolamide succinate, N-palmitoyl aspartic acid di-triethanolamine, and sodium caseinate.
在一个实施方案中,作为阳离子表面活性剂,例如可以列举硬脂基三甲基氯化铵、月桂基三甲基氯化铵等烷基三甲基铵盐,二硬脂基二甲基氯化铵二烷基二甲基铵盐,氯化聚(N,N’-二甲基-3,5-亚甲基哌啶鎓)、氯化鲸蜡基吡啶鎓等烷基吡啶鎓盐,烷基季铵盐、烷基二甲基苄基铵盐、烷基异喹啉鎓盐、二烷基吗啉鎓盐、POE-烷基胺、烷基胺盐、聚胺脂肪酸衍生物、戊醇脂肪酸衍生物、苯扎氯铵以及苄索氯铵等中的至少一种。In one embodiment, as the cationic surfactant, for example, alkyltrimethylammonium salts such as stearyltrimethylammonium chloride and lauryltrimethylammonium chloride, distearyldimethylammonium chloride, etc. Ammonium chloride dialkyldimethylammonium salt, poly(N,N'-dimethyl-3,5-methylenepiperidinium chloride), cetylpyridinium chloride and other alkylpyridinium salts, Alkyl quaternary ammonium salts, alkyl dimethyl benzyl ammonium salts, alkyl isoquinolinium salts, dialkylmorpholinium salts, POE-alkylamines, alkylamine salts, polyamine fatty acid derivatives, ammonium At least one of alcohol fatty acid derivatives, benzalkonium chloride and benzethonium chloride.
在一个实施方案中,作为两性表面活性剂,例如可以列举2-十一烷基-N,N,N-(羟乙基羧甲基)-2-咪唑啉钠、2-椰油基-2-咪唑啉氢氧化物-1-羧乙氧基二钠盐等咪唑啉系两性表面活性剂,2-十七烷基-N-羧甲基-N-羟乙基咪唑啉鎓甜菜碱、月桂基二甲基氨基乙酸甜菜碱、烷基甜菜碱、酰胺基甜菜碱以及磺基甜菜碱等甜菜碱系两性表面活性剂等中的至少一种。In one embodiment, as the amphoteric surfactant, for example, 2-undecyl-N,N,N-(hydroxyethylcarboxymethyl)-2-imidazolinium sodium, 2-cocoyl-2 -imidazoline hydroxide-1-carboxyethoxy disodium salt and other imidazoline amphoteric surfactants, 2-heptadecyl-N-carboxymethyl-N-hydroxyethylimidazolinium betaine, lauryl At least one of betaine-based amphoteric surfactants such as dimethylaminoacetic acid betaine, alkyl betaine, amido betaine, and sultaine.
在一个实施方案中,作为亲油性非离子表面活性剂,例如可以列举脱水山梨糖醇单油酸酯、脱水山梨糖醇单异硬脂酸酯、脱水山梨糖醇单月桂酸酯、脱水山梨糖醇单棕榈酸酯、脱水山梨糖醇单硬脂酸酯、脱水山梨糖醇倍半油酸酯、脱水山梨糖醇三油酸酯、五-2-乙基己酸二甘油脱水山梨糖醇酯、四-2-乙基己酸二甘油脱水山梨糖醇酯等脱水山梨糖醇脂肪酸酯类,单棉籽油脂肪酸甘油酯、单芥酸甘油酯、倍半油酸甘油酯、单硬脂酸甘油酯、α,α’-油酸焦谷氨酸甘油酯、单硬脂酸甘油酯等脂肪酸甘油酯类,单异硬脂酸二甘油酯、二异硬脂酸二甘油酯等聚甘油脂肪酸酯,单硬脂酸丙二醇酯等丙二醇脂肪酸酯类、硬化蓖麻油衍生物以及甘油烷基醚等中的至少一种。In one embodiment, examples of lipophilic nonionic surfactants include sorbitan monooleate, sorbitan monoisostearate, sorbitan monolaurate, sorbitan Alcohol monopalmitate, sorbitan monostearate, sorbitan sesquioleate, sorbitan trioleate, penta-2-ethylhexanoic acid diglyceryl sorbitan , tetra-2-ethylhexanoic acid diglyceride sorbitan esters and other sorbitan fatty acid esters, mono-cottonseed oil fatty acid glycerides, monoerucic acid glycerides, sesquioleic acid glycerides, glyceryl monostearate Fatty acid glycerides such as esters, α, α'-oleic acid pyroglutamic acid glyceryl ester, glyceryl monostearate, polyglyceryl fatty acid such as monoisostearic acid diglyceride, diisostearic acid diglyceride At least one of esters, propylene glycol fatty acid esters such as propylene glycol monostearate, hardened castor oil derivatives, and glycerin alkyl ethers.
在一个实施方案中,作为亲水性非离子表面活性剂,例如可以列举POE-脱水山梨糖醇单油酸酯、POE-脱水山梨糖醇单硬脂酸酯、POE-脱水山梨糖醇单油酸酯、POE-脱水山梨糖醇四油酸酯等POE-脱水山梨糖醇脂肪酸酯类,POE-山梨糖醇单月桂酸酯、POE-山梨糖醇单油酸酯、POE-山梨糖醇五油酸酯、POE-山梨糖醇单硬脂酸酯等POE-山梨糖醇脂肪酸酯类,POE-甘油单硬脂酸酯、POE-甘油单异硬脂酸酯、POE-甘油三异硬脂酸酯等POE-甘油脂肪酸酯类,POE-单油酸酯、POE-二硬脂酸酯、POE-单二油酸酯、二硬脂酸乙二醇酯等POE-脂肪酸酯类,POE-月桂基醚、POE-油烯基醚、POE-硬脂酰醚、POE-山萮酰醚、POE-2-辛基十二烷基醚、POE-胆甾烷醇醚等POE-烷基醚类,Pluronic(聚丙二醇与环氧乙烷的加聚物)等Pluronic型类,POE·POP-鲸蜡醚、POE·POP-2-癸基四癸醚、POE·POP-单丁醚、POE·POP-氢化羊毛脂、POE·POP-甘油醚等POE·POP-烷基醚类、POE-蓖麻油、POE-硬化蓖麻油、POE-硬化蓖麻油单异硬脂酸酯、POE-硬化蓖麻油三异硬脂酸酯、POE-硬化蓖麻油单焦谷氨酸单异硬脂酸二酯、POE-硬化蓖麻油马来酸等POE-蓖麻油硬化蓖麻油衍生物、POE-山梨糖醇蜂蜡等POE-蜂蜡·羊毛脂衍生物,椰子油脂肪酸二乙醇酰胺、月桂酸单乙醇酰胺、脂肪酸异丙醇酰胺等烷醇酰胺,POE-丙二醇脂肪酸酯、POE-烷基胺、POE-脂肪酸酰胺、蔗糖脂肪酸酯、POE-壬基苯基甲醛缩合物、烷基乙氧基二甲基氧化胺以及三油烯基磷酸等中的至少一种。In one embodiment, examples of the hydrophilic nonionic surfactant include POE-sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate Ester, POE-sorbitan tetraoleate and other POE-sorbitan fatty acid esters, POE-sorbitol monolaurate, POE-sorbitol monooleate, POE-sorbitol five Oleate, POE-sorbitol monostearate and other POE-sorbitol fatty acid esters, POE-glycerol monostearate, POE-glycerol monoisostearate, POE-glycerol triisostearate Ester, etc. POE-glycerin fatty acid esters, POE-monooleate, POE-distearate, POE-monooleate, distearic acid ethylene glycol ester, etc. POE-fatty acid esters, POE- Lauryl ether, POE-oleyl ether, POE-stearyl ether, POE-behenyl ether, POE-2-octyl dodecyl ether, POE-cholestanol ether, etc. POE-alkyl ethers Classes, Pluronic (addition polymer of polypropylene glycol and ethylene oxide) and other Pluronic types, POE·POP-cetyl ether, POE·POP-2-decyl tetradecyl ether, POE·POP-monobutyl ether, POE・POP-hydrogenated lanolin, POE・POP-glycerin ether, etc. POE・POP-alkyl ethers, POE-castor oil, POE-hardened castor oil, POE-hardened castor oil monoisostearate, POE-hardened castor Sesame oil triisostearate, POE-hardened castor oil monopyrglutamate monoisostearate, POE-hardened castor oil maleic acid, etc. POE-castor oil hardened castor oil derivatives, POE-sorbitol Beeswax and other POE-beeswax and lanolin derivatives, coconut oil fatty acid diethanolamide, lauric acid monoethanolamide, fatty acid isopropanolamide and other alkanolamides, POE-propylene glycol fatty acid ester, POE-alkylamine, POE-fatty acid At least one of amide, sucrose fatty acid ester, POE-nonylphenyl formaldehyde condensate, alkyl ethoxy dimethyl amine oxide, and trioleyl phosphoric acid.
在一个实施方案中,作为天然系表面活性剂,例如可以列举大豆磷脂、氢化大豆磷脂、卵黄磷脂、氢化卵黄磷脂等卵磷脂类或大豆皂角素等中的至少一种。In one embodiment, examples of natural surfactants include at least one of lecithins such as soybean lecithin, hydrogenated soybean lecithin, lecithin, hydrogenated egg yolk lecithin, soybean saponin, and the like.
在一个实施方案中,本发明组合物可以被加入到化妆品或药物递送系统和/或缓释系统中,所述化妆品或药物递送系统和/或缓释系统选自由以下组成的组:脂质体、混合脂质体、毫米微胶囊、微胶囊、纳米微胶囊、海绵、环糊精、囊泡、胶束、表面活性剂混合胶束、磷脂-表面活性剂混合胶束、毫米微球、微球、纳米微球、脂微球、微乳剂、纳米乳剂、毫米微粒、微粒、纳米微粒和固体脂质纳米微粒。In one embodiment, the composition of the invention may be incorporated into a cosmetic or pharmaceutical delivery system and/or sustained release system selected from the group consisting of liposomes , mixed liposomes, millimeter microcapsules, microcapsules, nanocapsules, sponges, cyclodextrins, vesicles, micelles, surfactant mixed micelles, phospholipid-surfactant mixed micelles, millimeter microspheres, micro spheres, nanospheres, lipospheres, microemulsions, nanoemulsions, millimeter particles, microparticles, nanoparticles and solid lipid nanoparticles.
在一个实施方案中,所述油性助剂可以选自液体油脂、固体油脂、蜡类、烃油、高级脂肪酸、高级醇、酯油、硅油中的至少一种。In one embodiment, the oily auxiliary agent can be selected from at least one of liquid oil, solid oil, wax, hydrocarbon oil, higher fatty acid, higher alcohol, ester oil, and silicone oil.
在一个实施方案中,作为液体油脂,例如可以列举鳄梨油、山茶油、鳖油、澳洲坚果油、玉米油、向日葵油、貂油、橄榄油、菜籽油、蛋黄油、芝麻油、杏仁油、小麦胚芽油、山茶花油、蓖麻油、亚麻子油、红花油、葡萄籽油、棉籽油、紫苏子油、大豆油、花生油、茶籽油、椰子油、米糠油、泡桐油、日本桐油、荷荷芭油、胚芽油、月见草油、三辛酸甘油酯以及三异棕榈酸甘油酯等中的至少一种。另外,这里的液体油脂指室温下为液体的油脂。In one embodiment, examples of liquid fats and oils include avocado oil, camellia oil, turtle oil, macadamia oil, corn oil, sunflower oil, mink oil, olive oil, rapeseed oil, egg oil, sesame oil, almond oil , wheat germ oil, camellia oil, castor oil, linseed oil, safflower oil, grape seed oil, cottonseed oil, perilla seed oil, soybean oil, peanut oil, tea seed oil, coconut oil, rice bran oil, paulownia oil, Japan At least one of tung oil, jojoba oil, germ oil, evening primrose oil, glyceryl tricaprylate, and glyceryl triisopalmitate. In addition, the liquid fats and oils here refer to fats and oils that are liquid at room temperature.
在一个实施方案中,作为固体油脂,例如可以列举可可脂、椰子油、牛脂、羊脂、马脂、棕榈仁油、猪脂、牛骨脂、树蜡油、牛脚脂、树蜡、硬化椰子油、硬化棕榈油、硬化牛脂、硬化油以及硬化蓖麻油等中的至少一种。In one embodiment, examples of solid fats include cocoa butter, coconut oil, tallow, suet, horse tallow, palm kernel oil, lard, bovine tallow, tree wax oil, tallow tallow, tree wax, hardened At least one of coconut oil, hardened palm oil, hardened tallow, hardened oil, hardened castor oil, and the like.
在一个实施方案中,作为蜡类,例如可以列举蜂蜡、小烛树蜡、棉蜡、棕榈蜡、杨梅蜡、虫蜡、鲸蜡、褐煤蜡、米糠蜡、木棉蜡、甘蔗蜡、羊毛脂、醋酸羊毛脂、液体羊毛脂、羊毛脂脂肪酸异丙酯、还原羊毛脂、硬质羊毛脂、月桂酸己酯、荷荷芭蜡、虫胶蜡、POE羊毛脂醇醚、POE羊毛脂醇乙酸酯、POE胆固醇醚、羊毛脂脂肪酸聚乙二醇以及POE氢化羊毛脂醇醚等中的至少一种。In one embodiment, examples of waxes include beeswax, candelilla wax, cotton wax, palm wax, bayberry wax, insect wax, spermaceti wax, montan wax, rice bran wax, kapok wax, sugarcane wax, lanolin, Lanolin acetate, liquid lanolin, isopropyl lanolin fatty acid ester, reduced lanolin, hard lanolin, hexyl laurate, jojoba wax, shellac wax, POE lanolin alcohol ether, POE lanolin alcohol acetate At least one of esters, POE cholesteryl ether, lanolin fatty acid polyethylene glycol, and POE hydrogenated lanolin alcohol ether.
在一个实施方案中,作为烃油,例如可以列举液体石蜡、异石蜡烃、重质液体异石蜡烃、石蜡烃、地蜡、角鲨烷、植物性角鲨烷、姥鲛烷、白地蜡、角鲨烯、凡士林、微晶蜡、石蜡、褐煤蜡、烯烃低聚物、聚异丁烯、聚丁烯以及氢化聚丁烯等中的至少一种。In one embodiment, examples of hydrocarbon oils include liquid paraffin, isoparaffin, heavy liquid isoparaffin, paraffin, ozokerite, squalane, vegetable squalane, pristane, ceresin, At least one of squalene, petrolatum, microcrystalline wax, paraffin wax, montan wax, olefin oligomers, polyisobutylene, polybutene, and hydrogenated polybutene.
在一个实施方案中,作为高级脂肪酸,例如可以列举月桂酸、肉豆蔻酸、棕榈酸、硬脂酸、山萮酸(Behenicacid)、油酸、十一碳烯酸、松浆油酸、异硬脂酸、亚油酸、亚麻酸、二十碳五烯酸(EPA)以及二十二碳六烯酸(DHA)等中的至少一种。In one embodiment, examples of higher fatty acids include lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, oleic acid, undecylenic acid, tall oleic acid, isohard At least one of fatty acid, linoleic acid, linolenic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).
在一个实施方案中,作为高级醇,例如可以列举月桂醇、鲸蜡醇、硬脂醇、山萮醇、肉豆蔻醇、油醇、十六硬脂醇等直链醇,单硬脂基甘油醚(鲨肝醇)、2-癸基十四烷醇、羊毛脂醇、胆固醇、植物甾醇、己基十二烷醇、异硬脂醇以及辛基十二烷醇等支链醇等中的至少一种。In one embodiment, examples of higher alcohols include linear alcohols such as lauryl alcohol, cetyl alcohol, stearyl alcohol, behenyl alcohol, myristyl alcohol, oleyl alcohol, and cetearyl alcohol; monostearyl glycerin At least one of branched chain alcohols such as ether (bakelyl alcohol), 2-decyltetradecanol, lanolin alcohol, cholesterol, phytosterol, hexyldodecanol, isostearyl alcohol, and octyldodecanol A sort of.
在一个实施方案中,作为酯油,例如可以列举肉豆蔻酸异丙酯、异辛酸鲸蜡酯、肉豆蔻酸辛基十二烷酯、棕榈酸异丙酯、棕榈酸异辛酯、硬脂酸丁酯、月桂酸己酯、肉豆蔻酸肉豆蔻酯、油酸癸酯、辛酸葵酸甘油三酯、二甲基辛酸己基癸酯、乳酸鲸蜡酯、乳酸肉豆蔻酯、乳酸辛基十二烷酯、醋酸羊毛脂、硬脂酸异鲸蜡酯、异硬脂酸异鲸蜡酯、12-羟基硬脂酸胆固醇酯、12-羟基硬脂酸植物甾醇酯、油酸植物甾醇酯、二-2-乙基己酸乙二醇酯、二癸酸丙二醇酯、二季戊四醇脂肪酸酯、单异硬脂酸N-烷基二醇酯、二癸酸新戊二醇酯、苹果酸二异硬脂酯、二-2-庚基十一烷酸甘油酯、三羟甲基丙烷三-2-乙基己酸酯、三羟甲基丙烷三异硬脂酸酯、四-2-乙基己酸季戊四醇酯、三-2-乙基己酸甘油酯、三(癸酰基·癸酸)甘油酯、三(癸酰基·三癸酸甘油酯·三肉豆蔻酸甘油酯·硬脂酸)甘油酯、三羟甲基丙烷三异硬脂酸酯、2-乙基己酸鲸蜡酯、棕榈酸2-乙基己酯、三肉豆蔻酸甘油酯、三-2-庚基十一烷酸甘油酯、二异硬脂酸聚甘油酯、三异硬脂酸聚甘油酯、四异硬脂酸聚甘油酯、三异硬脂酸二甘油酯、四异硬脂酸二甘油酯、三2-乙基己酸赤藓醇酯、二三羟甲基丙烷三-2-乙基己酸酯、(异硬脂酸/癸二酸)二三羟甲基丙烷低聚酯、蓖麻油脂肪酸甲酯、油酸油醇酯、醋酸甘油酯、棕榈酸2-庚基十一烷酯、己二酸二异丁酯、(己二酸·2-乙基己酸·硬脂酸)甘油低聚酯、(2-己基癸酸·癸二酸)二甘油酯低聚酯、N-月桂酰基-L-谷氨酸-2-辛基十二烷酯、己二酸二-2-庚基十一烷酯、月桂酸乙酯、癸二酸二-2-乙基己酯、肉豆蔻酸2-己基癸酯、棕榈酸2-己基癸酯、己二酸2-己基癸酯、癸二酸二异丙酯、琥珀酸2-乙基己酯、醋酸乙酯、醋酸丁酯以及柠檬酸三乙酯等中的至少一种。In one embodiment, as the ester oil, for example, isopropyl myristate, cetyl isooctanoate, octyldodecyl myristate, isopropyl palmitate, isooctyl palmitate, stearic acid Butyl, Hexyl Laurate, Myristyl Myristate, Decyl Oleate, Caprylic Triglyceride, Hexyldecyl Dimethyl Caprylate, Cetyl Lactate, Myristyl Lactate, Octyldodecyl Lactate Alkyl esters, lanolin acetate, isocetyl stearate, isocetyl isostearate, cholesterol 12-hydroxystearate, phytosteryl 12-hydroxystearate, phytosteryl oleate, -Ethylene glycol 2-ethylhexanoate, propylene glycol dicaprate, dipentaerythritol fatty acid ester, N-alkyl glycol monoisostearate, neopentyl glycol dicaprate, diisomalate Stearyl esters, glyceryl di-2-heptylundecanoate, trimethylolpropane tri-2-ethylhexanoate, trimethylolpropane triisostearate, tetrakis-2-ethyl Pentaerythritol caproate, Glyceryl tri-2-ethylhexanoate, Glyceryl tris(caproyl caprate), Glycerin tris(caproyl tricaprate Trimyristate stearate) Esters, Trimethylolpropane Triisostearate, Cetyl 2-Ethylhexanoate, 2-Ethylhexyl Palmitate, Glyceryl Trimyristate, Tri-2-Heptyl Undecanoate Glyceryl esters, polyglyceryl diisostearate, polyglyceryl triisostearate, polyglyceryl tetraisostearate, diglyceryl triisostearate, diglyceryl tetraisostearate, three 2 - Erythritol Ethylhexanoate, Ditrimethylolpropane Tris-2-Ethylhexanoate, (Isostearic/Sebacic) Ditrimethylolpropane Oligoester, Castor Oil Fatty Acid ester, oleyl oleate, glyceryl acetate, 2-heptyl undecyl palmitate, diisobutyl adipate, (adipate·2-ethylhexanoate·stearic acid) glycerol oligomerization Ester, (2-hexylcapric acid sebacic acid) diglyceride oligoester, N-lauroyl-L-glutamic acid-2-octyldodecyl ester, di-2-heptyldecyl adipate Monoalkyl esters, ethyl laurate, di-2-ethylhexyl sebacate, 2-hexyldecyl myristate, 2-hexyldecyl palmitate, 2-hexyldecyl adipate, sebacic acid At least one of diisopropyl, 2-ethylhexyl succinate, ethyl acetate, butyl acetate, and triethyl citrate.
在一个实施方案中,作为硅油,例如可以列举二甲基聚硅氧烷、甲基苯基聚硅氧烷、甲基氢聚硅氧烷等链状聚硅氧烷、八甲基环四硅氧烷、十甲基环五硅氧烷、十二甲基环六硅氧烷、四氢四甲基环四硅氧烷等环状聚硅氧烷以及聚氧乙烯聚烷基硅氧烷等中的至少一种。In one embodiment, examples of the silicone oil include chain polysiloxanes such as dimethylpolysiloxane, methylphenylpolysiloxane, and methylhydrogenpolysiloxane, octamethylcyclotetrasilicon, and the like. Oxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, tetrahydrotetramethylcyclotetrasiloxane and other cyclic polysiloxanes and polyoxyethylene polyalkylsiloxanes, etc. at least one of the
在一个实施方案中,所述油溶性助剂选自:荷荷芭油、辛酸葵酸甘油三酯、棕榈酸异辛酯、棕榈酸异丙酯、肉豆蔻酸肉豆蔻酯中的至少一种,优选地,所述油溶性助剂为荷荷巴油、辛酸葵酸甘油三酯、棕榈酸异辛酯中的至少一种。In one embodiment, the oil-soluble additive is selected from at least one of: jojoba oil, caprylic triglyceride, isooctyl palmitate, isopropyl palmitate, and myristyl myristate , preferably, the oil-soluble additive is at least one of jojoba oil, caprylic triglyceride, and isooctyl palmitate.
在一个实施方案中,所述油溶性助剂中荷荷巴油、辛酸葵酸甘油三酯、棕榈酸异辛酯,其质量配比为(1-7):(1-7):(1-7),例如,7:2:1、5:4:1、3:6:1、6:1:3、4:1:5、2:1:7优选为4:1:5。In one embodiment, jojoba oil, caprylic triglyceride, and isooctyl palmitate in the oil-soluble additives have a mass ratio of (1-7): (1-7): (1 -7), for example, 7:2:1, 5:4:1, 3:6:1, 6:1:3, 4:1:5, 2:1:7 is preferably 4:1:5.
在一个实施方案中,所述富勒烯为空心富勒烯、金属富勒烯、杂环富勒烯和内嵌富勒烯中的一种或几种。包括但不限于富勒烯C2n、M@C2n、M2@C2n、MA@C2n、M3N@C2n、M2C2@C2n、M2S@C2n、M2O@C2n和MxA3-xN@C2n中的任一种,其中,M和A均为金属元素,所述M和A均选自Sc、Y和镧系金属元素中的任意一种;30≤n≤60;0≤x≤3,优选地,所述富勒烯为C60、C70、C76、C84,Gd@C82及其衍生物中的任意一种或其混合物,进一步优选地,所述富勒烯为C60。In one embodiment, the fullerene is one or more of hollow fullerenes, metal fullerenes, heterocyclic fullerenes and internal fullerenes. Including but not limited to fullerenes C 2n , M@C 2n , M 2 @C 2n , MA@C 2n , M 3 N@C 2n , M 2 C 2 @C 2n , M 2 S@C 2n , M 2 Any of O@C 2n and M x A 3-x N@C 2n , wherein M and A are metal elements, and the M and A are selected from any of Sc, Y and lanthanide metal elements One; 30≤n≤60; 0≤x≤3, preferably, the fullerene is any one of C60, C70, C76, C84, Gd@C82 and its derivatives or a mixture thereof, more preferably Preferably, the fullerene is C60.
在一个实施方案中,本发明组合物作为液体制剂的形式例如可以是油性悬浮液、溶液剂,还可以是一种在使用前可用水或其它适宜的载体复配的干燥产品。这种液体制剂可含有常规的添加剂,诸如悬浮剂,例如山梨醇、甲基纤维素、明胶、羟乙基纤维素、羧甲基纤维素、硬脂酸铝凝胶或氢化食用脂肪;溶液剂的制备通常是通过将活性物质溶解在一种载体中,并在将其装入一种适宜的小瓶或安瓿前过滤消毒,然后密封。In one embodiment, the composition of the present invention may be in the form of a liquid preparation, such as an oily suspension, a solution, or a dry product that can be reconstituted with water or other suitable carriers before use. Such liquid preparations may contain conventional additives such as suspending agents, for example sorbitol, methylcellulose, gelatin, hydroxyethylcellulose, carboxymethylcellulose, aluminum stearate gel or hydrogenated edible fats; solutions It is usually prepared by dissolving the active substance in a carrier and filter sterilizing before filling into a suitable vial or ampoule, which is then hermetically sealed.
在一个实施方案中,本发明提供了一种富勒烯组合物制备水剂方法:将本发明的富勒烯组合物按照比例与水混合后,搅拌均匀,然后均质好,加入防腐剂和香精得到水剂。In one embodiment, the present invention provides a method for preparing an aqueous solution of a fullerene composition: after mixing the fullerene composition of the present invention with water in proportion, stirring evenly, and then homogenizing well, adding preservatives and Fragrances get water solutions.
在一个实施方案中,本发明组合物制成乳剂的形式,可包含常规的乳化剂,助乳剂、表面活性剂等。In one embodiment, the composition of the present invention is in the form of an emulsion, which may contain conventional emulsifiers, co-emulsion agents, surfactants and the like.
在一个实施方案中,本发明提供了一种富勒烯组合物制备乳剂方法:将本发明的富勒烯组合物按照比例与乳化剂混合,然后进行均质,成乳状液或膏体,加入防腐剂和香精得到乳剂。In one embodiment, the present invention provides a method for preparing an emulsion from a fullerene composition: mix the fullerene composition of the present invention with an emulsifier in proportion, then homogenize, form an emulsion or paste, add Preservatives and fragrances get emulsions.
在一个实施方案中,本发明提供本发明的组合物或分散体系在制备美容或化妆用品中的用途。In one embodiment, the invention provides the use of a composition or dispersion according to the invention for the preparation of a cosmetic or cosmetic product.
在一个实施方案中,本发明提供本发明的组合物或分散体系在制备用于美容或化妆的器械中的用途。In one embodiment, the invention provides the use of a composition or dispersion according to the invention for the preparation of a cosmetic or make-up device.
实施例Example
下面参照实施例进一步阐释本发明。对本发明的具体示例性实施方案的描述是为了说明和例证的目的。这些描述并非想将本发明限定为所公开的精确形式,并且很显然,根据本申请说明书的教导,可以进行很多改变和变化。对示例性实施例进行选择和描述的目的在于解释本发明的特定原理及其实际应用,从而使得本领域的技术人员能够实现并利用本发明的各种不同的示例性实施方案以及各种不同的选择和改变。The present invention is further explained below with reference to examples. The descriptions of specific exemplary embodiments of the present invention have been presented for purposes of illustration and description. These descriptions are not intended to limit the invention to the precise forms disclosed, and obviously many modifications and variations are possible in light of the teachings of the present specification. The exemplary embodiments were chosen and described in order to explain the specific principles of the invention and its practical application, thereby enabling others skilled in the art to make and use various exemplary embodiments of the invention, as well as various Choose and change.
实施例1:Example 1:
取富勒烯粉末,油溶性助剂,将它们的混合物混合均匀后,投入微射流高压均质机中,200MPa均质5次,然后将物料温度控制在15度,搅拌12h,离心过滤得到组合物。Take fullerene powder and oil-soluble additives, mix their mixture evenly, put it into a micro-jet high-pressure homogenizer, homogenize it for 5 times at 200MPa, then control the temperature of the material at 15 degrees, stir for 12 hours, and centrifugally filter to obtain a combination things.
利用透射电镜观察富勒烯组合物的状态,放大250000倍并未检测到颗粒物存在,说明富勒烯是溶解在辅料中的,结果如图1所示。The state of the fullerene composition was observed with a transmission electron microscope, and the presence of particles was not detected at a magnification of 250,000 times, indicating that the fullerene was dissolved in the auxiliary material. The results are shown in Figure 1.
实施例2:Example 2:
抗皱紧致眼霜anti wrinkle firming eye cream
实施例3:Example 3:
抗皱亮肤面霜Anti-Wrinkle Brightening Cream
实施例4:Example 4:
防脱固发洗发水anti hair loss shampoo
实施例5:皮肤透过率实验Embodiment 5: skin transmittance experiment
本发明富勒烯组合物按照实施例1制备。The fullerene composition of the present invention is prepared according to Example 1.
对照组:申请号:200480005008.1实施例1公开的胶束包覆的富勒烯复合物。Control group: application number: 200480005008.1 Fullerene complex coated with micelles disclosed in Example 1.
实验方法:选用乳猪皮作为实验对象,分别将富勒烯组合物(其中荷荷巴油:辛酸葵酸甘油三酯:棕榈酸异辛酯为4:5:1)与胶束包覆的富勒烯复合物进行透皮实验对比。采用LC-MS进行药物透过率分析。Experimental method: select suckling pigskin as the experimental object, respectively mix the fullerene composition (in which jojoba oil: capric acid triglyceride: isooctyl palmitate ratio is 4:5:1) and micelles-coated Fullerene complexes were compared in transdermal experiments. Drug permeability analysis was performed by LC-MS.
结果显示:6个小时后,本富勒烯组合物中有80%的透过率,胶束包覆的复合物透过率仅为20%。The results show that after 6 hours, the fullerene composition has a transmittance of 80%, and the compound coated with micelles has a transmittance of only 20%.
结论:本发明含富勒烯的组合物为亮紫色,其中富勒烯为溶解状态,得到的含富勒烯的组合物性质稳定,可用于任何外用配方,非常易于透过皮肤角质层,更易于吸收和利用,功效更容易发挥。Conclusion: the fullerene-containing composition of the present invention is bright purple, wherein fullerene is in a dissolved state, and the obtained fullerene-containing composition is stable in properties, can be used for any external formulation, and is very easy to penetrate the stratum corneum of the skin. It is easy to absorb and utilize, and the efficacy is easier to exert.
实施例6:油溶性助剂的配制Embodiment 6: the preparation of oil-soluble auxiliary agent
取富勒烯粉末,油溶性助剂,将它们的混合物混合均匀后,投入微射流高压均质机中,200MPa均质5次,然后将物料温度控制在15度,搅拌12h,离心过滤得到组合物。Take fullerene powder and oil-soluble additives, mix their mixture evenly, put it into a micro-jet high-pressure homogenizer, homogenize it for 5 times at 200MPa, then control the temperature of the material at 15 degrees, stir for 12 hours, and centrifugally filter to obtain a combination thing.
富勒烯在单一辅料中的溶解性Solubility of fullerenes in single excipients
液相标定其中富勒烯的含量为1mg/ml,表明富勒烯有效溶于上述配比的油溶性助剂。The content of fullerene in the liquid phase calibration is 1 mg/ml, which shows that fullerene is effectively soluble in the above-mentioned ratio of oil-soluble additives.
荷荷芭油是植物性油脂,虽然较其他植物油如橄榄油、亚麻籽油等要稳定很多,但是还是存在油脂的一定不稳定性。辛酸葵酸甘油三酯:高清爽度无味油脂,属棕榈油或椰子油的衍生物,它是使用热分馏方法提取。由于它和人体皮肤有兼容的特征,它有着不油腻质感,加入乳霜或乳液中可改进其延伸性,有润滑和使肌肤柔软的效果。并有过滤紫外光的功能,为椰子中的提取物,化妆品中作柔润剂、溶剂来使用。榈酸异辛酯:具有一定的透皮性,且性质温和。综合考察以上不同配比的组合物,发现荷荷巴油:辛酸葵酸甘油三脂:棕榈酸异辛酯4:5:1的配比条件下,组合物的稳定性更好,皮肤吸收性最佳,肤感更加温和。Jojoba oil is a vegetable oil. Although it is much more stable than other vegetable oils such as olive oil and linseed oil, it still has a certain degree of instability. Caprylic Capric Triglyceride: A high-strength, odorless oil derived from palm oil or coconut oil, which is extracted using thermal fractionation. Due to its compatibility with human skin, it has a non-greasy texture, which can be added to creams or lotions to improve its extensibility, lubricate and soften the skin. And it has the function of filtering ultraviolet light. It is an extract from coconut and used as emollient and solvent in cosmetics. Isooctyl Palmitate: It has a certain transdermal property and is mild in nature. Comprehensively inspecting the above compositions with different ratios, it is found that under the ratio of jojoba oil: capric acid triglyceride: isooctyl palmitate 4:5:1, the stability of the composition is better, and the skin absorbability is better. Optimum, with a milder skin feel.
实施例7:美白祛斑效果Embodiment 7: Whitening and Freckle Removing Effect
实验方法:将小鼠用2.5%戊巴比妥钠麻醉后,模型组以0.4%的黄体酮注射液按0.02g/kg剂量小鼠后肢肌肉注射,每周6次,连续4周。正常组按0.02g/kg肌肉注射灭菌注射用水。取健康雌性小鼠60只,3个剂量组,随机分为6组,每组10只。正常组、模型组、一组富勒烯组合物(其中荷荷巴油:辛酸葵酸甘油三酯:棕榈酸异辛酯为4:5:1)外用3个剂量组(0.10、0.20、0.40mg/ml))、3%氢醌阳性对照组(0.69mg/ml)。一组3个剂量治疗组分别在小鼠造模当日皮肤局部外用给药,每日1次,连续用药30天。正常组和模型组于相应时间给予蒸馏水局部涂抹;3%氢醌阳性药对照组于造模当日开始局部用药,时间和疗程同富勒烯组。给药30天后,颈椎脱臼处死小鼠,背部去毛,迅速取肝组织及涂药部位的皮肤组织各2块,其中一块用冰冷的生理盐水冲洗,除去血液,滤纸吸干,切取肝脏及皮肤各0.5g,分别放入2.0ml预冷生理盐水的烧杯中,剪碎组织,再倒人试管中,以高速分散器10r/min匀浆两次,每次10秒;再以3500r/rain转速离心15分钟,取上清液,进行测试。Experimental method: After the mice were anesthetized with 2.5% pentobarbital sodium, the model group was intramuscularly injected with 0.4% progesterone injection at a dose of 0.02 g/kg in the hind limbs of the mice, 6 times a week for 4 consecutive weeks. The normal group was injected intramuscularly with sterile water for injection at 0.02g/kg. Take 60 healthy female mice, 3 dosage groups, and divide them into 6 groups randomly, 10 in each group. Normal group, model group, and a group of fullerene compositions (in which jojoba oil: caprylic triglyceride: isooctyl palmitate is 4:5:1) externally applied 3 dosage groups (0.10, 0.20, 0.40 mg/ml)), 3% hydroquinone positive control group (0.69mg/ml). A group of 3 doses of the treatment group were administered externally on the skin of mice on the day of modeling, once a day, for 30 consecutive days. The normal group and the model group were given local application of distilled water at the corresponding time; the 3% hydroquinone positive drug control group started topical application on the day of modeling, and the time and course of treatment were the same as those of the fullerene group. After 30 days of administration, the mice were killed by cervical dislocation, and the hair on the back was removed. Two pieces of liver tissue and two pieces of skin tissue were quickly taken from the drug-applied site, one of which was washed with ice-cold normal saline to remove blood, blotted dry with filter paper, and the liver and skin were cut out. Put 0.5g each into a beaker of 2.0ml pre-cooled normal saline, cut the tissue into pieces, then pour it into a test tube, and homogenize twice with a high-speed disperser at 10r/min, each time for 10 seconds; then at a speed of 3500r/rain Centrifuge for 15 minutes and take the supernatant for testing.
结果:如下表2Result: Table 2 below
表2Table 2
结论:如上表2所示,正常组为未造模,模型组为造模后为进行药物处理,阳性组为已知具有优良美白效果的氢醌。造模成功后,模型组的黑素细胞数明显增多,真皮炎症细胞数增多,真皮血管数减少,对比低、中、高三个给药组发现其黑素细胞数量、真皮炎细胞均比模型组低,真皮血管数明显增加,说明都有一定的美白效果,并且有一定的浓度依赖关系。本发明组合物对于模型组、阳性对照组具有显著功效,本发明的组合物具有美白祛斑的作用。Conclusion: As shown in Table 2 above, the normal group is without modeling, the model group is treated with drugs after modeling, and the positive group is hydroquinone, which is known to have excellent whitening effects. After successful modeling, the number of melanocytes in the model group increased significantly, the number of dermal inflammatory cells increased, and the number of dermal blood vessels decreased. Compared with the low, medium, and high administration groups, the number of melanocytes and dermal inflammatory cells were significantly higher than those in the model group. Low, the number of dermal blood vessels increased significantly, indicating that both have a certain whitening effect, and there is a certain concentration-dependent relationship. The composition of the invention has remarkable effects on the model group and the positive control group, and the composition of the invention has the effect of whitening and removing spots.
实施例8:抗氧化除皱Example 8: anti-oxidation and anti-wrinkle
实验方法:实验选用6周大裸鼠,分为两组,每组10只,实验组在裸鼠右侧耳背部涂抹油溶性富勒烯组合物(其中荷荷巴油:辛酸葵酸甘油三酯:棕榈酸异辛酯为4:5:1),每日两次,每次约0.5g,对照组不给药。在清洁、通风、干燥、室温22±2℃条件下,相同饲料喂养。用药60天后各取8只,颈椎脱臼处死后取其药物作用部位及对侧相应部位皮肤作检测。观察60天实验组水溶性富勒烯外用组合物对皮肤胶原蛋白占真皮层面积比例的影响。结果:见表3,60天后本发明组合物对真皮层胶原蛋白的增加有显著效果。Experimental method: 6-week-old nude mice were used in the experiment, and were divided into two groups, 10 in each group. The experimental group applied an oil-soluble fullerene composition (jojoba oil: capric acid triglyceride capric acid) to the back of the right ear of the nude mice. Esters: isooctyl palmitate (4:5:1), twice a day, about 0.5g each time, the control group did not administer. Under the conditions of clean, ventilated, dry, room temperature 22±2°C, the same feed was fed. After 60 days of medication, 8 rats were taken respectively, and after being killed by cervical dislocation, the skin of the drug-acting part and the corresponding part of the contralateral side were taken for detection. Observe the effect of the water-soluble fullerene external composition in the experimental group for 60 days on the ratio of skin collagen to the area of the dermis. Result: See Table 3, after 60 days, the composition of the present invention has a significant effect on the increase of dermis collagen.
表3油溶性富勒烯外用组合物对皮肤胶原蛋白占真皮层面积比例的影响Table 3 The influence of oil-soluble fullerene composition for external application on skin collagen accounted for dermis layer area ratio
实施例9:本发明富勒烯组合物配方人体外用效果评价Example 9: Evaluation of the effect of the fullerene composition formulation of the present invention on human body for external use
在常规乳液中加入该组合物,配制成新的乳液产品。The composition is added into conventional emulsion to prepare a new emulsion product.
祛痘实验:性别随机,20名年龄18~55岁,面部有轻度、中度和重度的痤疮的受试者,使用产品14天,结果如图2和3所示。Anti-acne experiment: Gender randomized, 20 subjects aged 18-55 with mild, moderate and severe facial acne, used the product for 14 days, the results are shown in Figures 2 and 3.
淡化细纹实验:20名年龄35-55岁女性,眼角处有明显皱纹,使用产品30天Fade fine line experiment: 20 women aged 35-55, with obvious wrinkles at the corners of the eyes, use the product for 30 days
肤色改善实验:20名年龄35-55岁女性,肤色暗沉,连续使用4周含有3%本专利成分的富勒烯的面霜,每日早晚各一次。通过问卷调查及照片分析获得数据。可以看出添加了3%富勒烯的面霜具有明显的提亮肤色,美白的功效。结果如图4所示Skin color improvement experiment: 20 women aged 35-55 with dull complexion used the face cream containing 3% fullerene of this patented ingredient for 4 consecutive weeks, once a day in the morning and evening. Data were obtained through questionnaire survey and photo analysis. It can be seen that the face cream added with 3% fullerene has obvious skin brightening and whitening effects. The result is shown in Figure 4
淡斑实验:20名年龄35-55岁女性,局部有浅褐色斑块,使用产品30天Spot lightening experiment: 20 women aged 35-55, with light brown spots locally, used the product for 30 days
固发防脱实验:有脱发困扰人群,性别不限,使用产品30天Anti-hair loss experiment: People with hair loss problems, regardless of gender, use the product for 30 days
防霾效果:将本专利富勒烯组合物(其中荷荷巴油:辛酸葵酸甘油三酯:棕榈酸异辛酯为4:5:1)处理皮肤外植体5天,然后暴露于污染环境中。结果显示经过本专利成分处理的皮肤细胞状态与空白组几乎没有差别。而被雾霾损伤过的皮肤表现出受损细胞明显增多,结果如图5所示。Anti-smog effect: the patented fullerene composition (wherein jojoba oil: caprylic triglyceride: isooctyl palmitate is 4:5:1) was used to treat skin explants for 5 days, and then exposed to pollution Environment. The result shows that the state of the skin cells treated with the ingredients of this patent has almost no difference from the blank group. The skin damaged by haze showed a significant increase in damaged cells, the results are shown in Figure 5.
结果:result:
结论:本发明的富勒烯组合物具有美容作用,祛痘,消除细纹,改善肤色淡斑效果。Conclusion: the fullerene composition of the present invention has a cosmetic effect, can remove acne, eliminate fine lines, and improve the effect of skin lightening.
综上所述本发明有益效果In summary the beneficial effects of the present invention
1、本发明的含富勒烯组合物中富勒烯为分子状态,颗粒粒径小,在配方中更容易释放出,进而被吸收利用。1. The fullerene in the fullerene-containing composition of the present invention is in molecular state, and the particle size is small, so it is easier to release in the formulation and then be absorbed and utilized.
2、本发明的含富勒烯的组合物制备方法简便易行,适合大批量制备。2. The preparation method of the fullerene-containing composition of the present invention is simple and easy, and is suitable for mass production.
3、本发明的含富勒烯的组合物性质稳定,适用于任何外用配方的制备。3. The fullerene-containing composition of the present invention has stable properties and is suitable for the preparation of any external formulation.
4、本发明的含富勒烯的组合物具有美白、祛斑、祛皱的作用。4. The fullerene-containing composition of the present invention has the functions of whitening, freckle removing and wrinkle removing.
Claims (10)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810777244.9A CN108852865A (en) | 2018-07-16 | 2018-07-16 | A kind of fullerene topical composition |
| CN201811299206.3A CN109498478B (en) | 2018-07-16 | 2018-11-02 | Oil-soluble fullerene topical composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810777244.9A CN108852865A (en) | 2018-07-16 | 2018-07-16 | A kind of fullerene topical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108852865A true CN108852865A (en) | 2018-11-23 |
Family
ID=64302312
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810777244.9A Pending CN108852865A (en) | 2018-07-16 | 2018-07-16 | A kind of fullerene topical composition |
| CN201811299206.3A Active CN109498478B (en) | 2018-07-16 | 2018-11-02 | Oil-soluble fullerene topical composition |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811299206.3A Active CN109498478B (en) | 2018-07-16 | 2018-11-02 | Oil-soluble fullerene topical composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN108852865A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109464288A (en) * | 2018-12-06 | 2019-03-15 | 上海莎伦巍化学科技有限公司 | A kind of fowler ene compositions and the Essence containing the fowler ene compositions |
| CN110946789A (en) * | 2019-12-31 | 2020-04-03 | 茂名市瑜丰沉香创意产业有限公司 | Hand cream containing agilawood and fullerene and preparation method thereof |
| CN113599307A (en) * | 2021-08-17 | 2021-11-05 | 北京福纳康生物技术有限公司 | Fullerene composition for hair care |
| US11253443B2 (en) | 2020-01-22 | 2022-02-22 | Max C. Champie | Skin products with C60 and niacin |
| CN114652619A (en) * | 2022-05-09 | 2022-06-24 | 中国科学院烟台海岸带研究所 | Active oil-soluble anthocyanin and preparation method and application thereof |
| CN117243840A (en) * | 2023-10-17 | 2023-12-19 | 广州广纳慧川科技有限公司 | Fullerene repair moisturizing cream and preparation method and application thereof |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110384641A (en) * | 2019-08-12 | 2019-10-29 | 中山市博深化学有限公司 | Skin care composition containing fullerene, eye cream and preparation method of eye cream |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009113426A1 (en) * | 2008-03-14 | 2009-09-17 | 財団法人ひろしま産業振興機構 | Anti-wrinkle composition and external skin composition |
| CN108201513B (en) * | 2016-12-16 | 2021-04-06 | 北京福纳康生物技术有限公司 | Hair composition and hair restorer |
| CN107519046A (en) * | 2017-08-01 | 2017-12-29 | 深圳慧镁尔科技有限公司 | A kind of anticreep strengthen the hair hair growth composition, preparation method and applications |
-
2018
- 2018-07-16 CN CN201810777244.9A patent/CN108852865A/en active Pending
- 2018-11-02 CN CN201811299206.3A patent/CN109498478B/en active Active
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109464288A (en) * | 2018-12-06 | 2019-03-15 | 上海莎伦巍化学科技有限公司 | A kind of fowler ene compositions and the Essence containing the fowler ene compositions |
| CN110946789A (en) * | 2019-12-31 | 2020-04-03 | 茂名市瑜丰沉香创意产业有限公司 | Hand cream containing agilawood and fullerene and preparation method thereof |
| US11253443B2 (en) | 2020-01-22 | 2022-02-22 | Max C. Champie | Skin products with C60 and niacin |
| CN113599307A (en) * | 2021-08-17 | 2021-11-05 | 北京福纳康生物技术有限公司 | Fullerene composition for hair care |
| CN114652619A (en) * | 2022-05-09 | 2022-06-24 | 中国科学院烟台海岸带研究所 | Active oil-soluble anthocyanin and preparation method and application thereof |
| CN114652619B (en) * | 2022-05-09 | 2023-12-12 | 中国科学院烟台海岸带研究所 | Active oil-soluble anthocyanin as well as preparation method and application thereof |
| CN117243840A (en) * | 2023-10-17 | 2023-12-19 | 广州广纳慧川科技有限公司 | Fullerene repair moisturizing cream and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN109498478B (en) | 2021-01-29 |
| CN109498478A (en) | 2019-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108904302B (en) | Water-soluble fullerene external composition | |
| CN109498478B (en) | Oil-soluble fullerene topical composition | |
| RU2537235C2 (en) | Mildly acting indelible compositions for skin care | |
| CN107411983B (en) | A kind of water-soluble fullerene external use composition | |
| EP0447318B1 (en) | Composition for the cosmetic and/or pharmaceutical treatment of the surface epidermal layers by topical application on the skin and the relative production process | |
| JP3142245B2 (en) | External preparation for skin | |
| TWI287995B (en) | Dermatological composition containing co-enzyme Q as active ingredient | |
| JP2007522205A (en) | Multilamellar liposome and production method thereof | |
| KR101443180B1 (en) | Novel Drug Delivery System for Percutaneous Absorption, Composition for External Preparation Preventing Hair Loss, and Cosmetics Using the Same | |
| JP2006028148A (en) | Composition for external use | |
| JP2003026546A (en) | Hair restorer composition | |
| KR101775266B1 (en) | Novel tranexamic acid-loaded liquid crystalline nanoparticles and process for preparing the same | |
| JP2002193734A (en) | Composition for external use | |
| JP2572730B2 (en) | Skin cosmetics | |
| BR112013033169B1 (en) | COMPOSITION COMPRISING A FIRST ONION EXTRACT (A) AND LIPOSOMES AND METHOD FOR PREPARING A COMPOSITION | |
| KR101626473B1 (en) | Composition for external application to the skin containing cyclohexane dicarboxylic acid derivatives | |
| KR101761005B1 (en) | Cosmetic composition containing non-toxic sulfur for sikn moisture, anti-inflammatory and immune enhancement and manufacturing the same | |
| KR102283326B1 (en) | Cosmetic compositions containing Fermented products of Lactobacillus, Fermented products of Lactococcus, Sacchromyces peptide, Lactobacillus acidophilus/grape ferment | |
| KR101322850B1 (en) | The cosmetic composition for pore-minimizing and inhibition of Sebum Secretion containing the extract of leaves of Mentha arvensis var. piperascens, wheat bud, and Platycodon grandiflorum | |
| JP2005213187A (en) | Involucrin production promoter | |
| JP2004307470A (en) | Use of monoesters or diesters of cinnamic acid or its derivatives with vitamin C as NO donor | |
| RU2383328C2 (en) | Transdermal gel for area around eyes "silky touch" | |
| JP2004307469A (en) | Use of N-arylmethyleneethylenediaminetriacetate, N-arylmethyleneiminodiacetate or N, N'-diarylmethyleneethylenediamine acetate as NO donor | |
| JP6807636B2 (en) | Topical composition | |
| JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181123 |